Quest Diagnostics Inc

DGX: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|Z%LOCK|$VY<$LOCK|rWJkPb>

Quest Diagnostics Earnings: Robust Quarterly Results Held Few Surprises; Our Valuation Is Intact

Quest delivered third-quarter results that featured organic revenue growth of 4%, while acquisitions drove total revenue up by 13%. Profitability kept pace with adjusted EPS, growing 13% year over year.

Sponsor Center